Business Wire

Tusk Innovation Announces New Products Black Friday

17.11.2022 11:06:00 EET | Business Wire | Press release

Share

Tusk Inc. Limited (www.tusklimited.com) a company which started in 2012 as a capital management company in Kuala Lumpur with offices around the world, and now is one of the leading electrical solution companies which focus on producing for users of mining equipment, solar energy and adapters is announcing is announcing new products for Black Friday. The Product line is mainly for electrical purposes. See more here https://tusklimited.com/products

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116005532/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

This product is sold with a 7in 1 Solar Panel, so you don’t have to pay for the panel. (Photo: Business Wire)

As one of the top Electrical solution companies, Tusk innovation has announced 30% Black Friday discounts on its combo of mining equipment, which combines a solar panel with a bitcoin miner. They do this to enable uninterrupted mining without a connection to any significant electricity, as electricity has been a major issue in the mining industry.

With their recent movement from polycrystalline to photovoltaic materials, Tusk innovation has tested over time the efficiency of combining their solar products with cryptocurrency miners, and this has proven to be the most effective. Tusk innovation investors can now with ease, mine their coins without interruptions, lesser risks and maximum profit.

This is an effort to reduce the amount of electricity used when clients mine cryptocurrencies, and it was disclosed by the COO, John Walls, last week. According to Walls, "Reports going around made it evident that the quantity of electricity miners require may be too large to handle, therefore we obtained a plausible option."

Mining Profits

Although it is admirable and highly profitable for many people to set up cryptocurrency mining farms, speculations are rife that they may incur significant costs, particularly in terms of electricity use. By providing you with a Solar Panel that is unconnected to your electricity bills and a bitcoin mining device that can perform dual mining tasks, Tusk Inc has created a long-lasting solution. You can simply mine your coins and not bother about the market's volatility.

Located in the heart of Kuala Lumpur, Malaysia, and United Kingdom, Tusk Inc has distinguished itself from others, in that customers can get crypto wallet development services as well as graphics processing units from the company, which has offices on three continents. It also has extensive experience in Blockchain development and bitcoin mining solutions, among other areas.

About Tusk

Established in 2012 by team of management experts, and later joined by a team of technology experts, Tusk Inc is now one of the leading electrical solution providers. They pride themselves also in their ability to manage risk effectively, since they have been in the business of managing risks for over a decade. And through several advancements in technology, they have incorporated less risky ventures into the Risk Management system, one of which is cryptocurrency mining, using photovoltaic materials.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

John Walls
PR Manager
john@tusklimited.com
(+60)1117000943

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release

VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye